|
| 36219586 | A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study. | Blood Adv | 2023 |
| 37805142 | Proceedings of the 2023 Second Annual ASTCT-NMDP ACCESS Initiative Workshop. | Transplant Cell Ther | 2023 |
| 37031746 | Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy. | Transplant Cell Ther | 2023 |
| 36399695 | Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial. | J Clin Oncol | 2023 |
| 36757731 | Access offsets poverty in quest for CAR T cells. | Blood | 2023 |
| 34534280 | Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease. | Blood | 2022 |
| 36044977 | Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study. | Transplant Cell Ther | 2022 |
| 36184058 | The ASTCT-NMDP ACCESS Initiative: A Collaboration to Address and Sustain Equal Outcomes for All across the Hematopoietic Cell Transplantation and Cellular Therapy Ecosystem. | Transplant Cell Ther | 2022 |
| 34855460 | Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies. | J Clin Oncol | 2022 |
| 34304802 | Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy. | Transplant Cell Ther | 2021 |
| 33529419 | Prolonged hematologic toxicity following treatment with chimeric antigen receptor T cells in patients with hematologic malignancies. | Am J Hematol | 2021 |
| 34461278 | Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year. | Transplant Cell Ther | 2021 |
| 32617981 | Hematopoietic stem cell transplantation for people with sickle cell disease. | Cochrane Database Syst Rev | 2020 |
| 32047896 | Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies. | Blood | 2020 |
| 32018062 | A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease. | Biol Blood Marrow Transplant | 2020 |
| 32044400 | Study 275: Updated Expanded Access Program for Remestemcel-L in Steroid-Refractory Acute Graft-versus-Host Disease in Children. | Biol Blood Marrow Transplant | 2020 |
| 33220230 | In Regard to Wong et al. | Int J Radiat Oncol Biol Phys | 2020 |
| 32706891 | Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter study. | Blood Adv | 2020 |
| 31043425 | Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria. | Blood | 2019 |
| 31267709 | Extracellular vesicles impose quiescence on residual hematopoietic stem cells in the leukemic niche. | EMBO Rep | 2019 |
| 31606419 | Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial. | Lancet Oncol | 2019 |
| 31158502 | Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation. | Biol Blood Marrow Transplant | 2019 |
| 29385370 | Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia. | N Engl J Med | 2018 |
| 30018082 | Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia. | Sci Signal | 2018 |
| 29933069 | Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression. | Biol Blood Marrow Transplant | 2018 |
| 29954931 | A phase II/III randomized, multicenter trial of prednisone/sirolimus <i>versus</i> prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-<i>versus</i>-host disease: BMT CTN 0801. | Haematologica | 2018 |
| 30275569 | Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia. | Nat Med | 2018 |
| 29581480 | Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation. | Bone Marrow Transplant | 2018 |
| 29753157 | Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric Blood and Marrow Transplant Consortium. | Biol Blood Marrow Transplant | 2018 |
| 28602958 | Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders. | Biol Blood Marrow Transplant | 2017 |
| 28396162 | Phase I Study of Clofarabine and 2-Gy Total Body Irradiation as a Nonmyeloablative Preparative Regimen for Hematopoietic Stem Cell Transplantation in Pediatric Patients with Hematologic Malignancies: A Therapeutic Advances in Childhood Leukemia Consortium Study. | Biol Blood Marrow Transplant | 2017 |
| 26825712 | Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. | Blood | 2016 |
| 27194464 | Hematopoietic stem cell transplantation for people with sickle cell disease. | Cochrane Database Syst Rev | 2016 |
| 27167353 | Marrow harvesting: practice makes perfect. | Transfusion | 2016 |
| 26711114 | Corrigendum: The genomic landscape of juvenile myelomonocytic leukemia. | Nat Genet | 2016 |
| 25445638 | Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era. | Biol Blood Marrow Transplant | 2015 |
| 26457647 | The genomic landscape of juvenile myelomonocytic leukemia. | Nat Genet | 2015 |
| 25865650 | Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia. | Biol Blood Marrow Transplant | 2015 |
| 25445641 | Nonmyeloablative allogeneic hematopoietic stem cell transplant for the treatment of patients with hematologic malignancies using busulfan, fludarabine, and total body irradiation conditioning is effective in an elderly and infirm population. | Biol Blood Marrow Transplant | 2015 |
| 24216185 | Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients. | Biol Blood Marrow Transplant | 2014 |
| 25196857 | Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial. | Biol Blood Marrow Transplant | 2014 |
| 24440648 | Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia. | Biol Blood Marrow Transplant | 2014 |
| 24077685 | Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study. | Support Care Cancer | 2014 |
| 22811079 | Immune markers of disease severity and treatment response in pediatric acquired aplastic anemia. | Pediatr Blood Cancer | 2013 |
| 23883618 | Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group. | Biol Blood Marrow Transplant | 2013 |
| 23838095 | Exposure of early pediatric trainees to blood and marrow transplantation leads to higher recruitment to the field. | Biol Blood Marrow Transplant | 2013 |
| 23728664 | Hematopoietic stem cell transplantation for people with sickle cell disease. | Cochrane Database Syst Rev | 2013 |
| 22905850 | Relapse after first allogeneic stem cell transplant for hematologic malignancies in children: should we do it again? | Pediatr Transplant | 2012 |
| 20685259 | Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies. | Biol Blood Marrow Transplant | 2011 |
| 21968355 | Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised children and healthy adults. | Antimicrob Agents Chemother | 2011 |